Shaping the Future: Bioanalytical Testing Services Market Trends and Forecasts for 2028

Table of Contents

Global Bioanalytical Testing Services Market Overview:

According to MarkNtel Advisors study the Global Bioanalytical Testing Services market is projected to grow at a CAGR of around 15.35% during the forecast period, 2023-28. The incessant need for Oral and Topical Drugs due to a consistent surge in the diagnosis of diseases has resulted in their high production. In addition to this, the increasing number of contract manufacturing companies like Icon, etc., expanding their development capacities across the globe to support the growing volume of batch production of biologics development, has assisted the growth of the Bioanalytical testing services.

Key Findings of the Study: Bioanalytical Testing Services market

Global Bioanalytical Testing Services Market Key Trend:

Development of Rapid technology for early diagnosis – The rise in the spread of the COVID-19 pandemic and the increasing prevalence of diseases like tuberculosis, HIV, etc., among the residents, have notably increased the focus of many biotech and pharmaceutical companies to develop effective drugs for diagnosis. This has pushed various companies like Cirion Biopharma, CD biosciences, etc., to develop rapid technology for early detection of the disease with accuracy for the detection and ensure the appropriateness of the drug in all healthcare settings, which is catalyzing the demand for Bioanalytical testing services in Healthcare.

In case you missed it, we are currently revising our reports. Click on the “request sample report“ button to get the latest research data with forecast for the years 2024 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.

Scope of the Bioanalytical Testing Services Market Report Segmentation

-By Test Type

Cell-Based Assay
Virology Testing
Method validation and Optimization
Serology, Immunogenicity and Neutralizing Antibodies
Biomarker testing
Pharmacokinetic testing
Others

-By Application

Oncology
Neurology
Infectious disease
Cardiology
Gastroenterology
Others

-By Molecule Type

Small Molecule
Large Molecule

-By End User

Pharmaceutical & Biotechnology Companies
Contractual Development & Manufacturer Organisation
Contract Research Organisation

For more detailed information about the Bioanalytical Testing Services market report, click here – https://www.marknteladvisors.com/research-library/bioanalytical-testing-services-market.html

Geographical analysis:

-By Region

North America
South America
Europe
The Middle East & Africa
Asia-Pacific

North America dominated the bioanalytical Testing Services market in 2022, owing to the rising drug development activities in the region to develop effective drugs to cure the growing number of communicable & genomic diseases.

The region holds the largest share due to the occurrence of various chronic diseases like Diabetes, Cancer, etc., which leads to increased adoption of large molecule therapeutics as an alternative to small molecules that can lead to side effects. For instance: According to the International Diabetes Federation, in 2021, about 51 million adults in North America were living with diabetes, and the disease occurrence would continue to grow in the coming years. Consequently, companies such as Charles River, CD Biosciences, etc., have been taking initiatives to develop effective drugs and increase the testing volume to meet the higher need for bioanalysis of novel therapeutics to stop the growing number of diabetic patients.

Global Bioanalytical Testing Services Industry Recent Developments

In 2022, Alta Science announced the expansion of its facility in Colombia, Missouri to provide bioanalytical service to support preclinical and clinical studies, and offers services including mass spectroscopy, flow cytometry, cell cultures, and others.
In 2022, SGS SA announced the expansion of its bioanalytical testing laboratory, in Shanghai, China. That includes the study of liposomes, albumin binding, proteins, peptides, and small nucleic and poly-nucleic acids to gather critical data and submit drug declarations to get their products to market quickly and safely.

Current Landscape of Bioanalytical Testing Services Market

The report delineates key market participants and thoroughly assesses their strategic approaches, trends, innovations, and manufacturing infrastructure, enabling a forecast of their market impact over the next five years. The meticulously researched data presented holds the potential to distinguish even nascent market entrants in the long term. Armed with pertinent data and actionable insights, our research report delivers a comprehensive overview of the market, empowering investors and stakeholders to establish a robust presence in the Bioanalytical Testing Services market. The research report profiles major players, including

Customization of Reports Available – https://www.marknteladvisors.com/query/request-customization/bioanalytical-testing-services-market.html

Charles River
Medpace holdings
ICON plc
Wuxi Apptech
Eurofins Scientific
Syenos Health
SGS SA
Intertek
PPD Inc.
Bioneeds India Pvt Ltd.
CD Bioscience Ltd.
Pace Analytical
BioAgilitix
Alta Sciences
Others

Related Reports

Why choose MarkNtel?

MarkNtel Advisors is a leading market research company, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 14.8 diverse industrial verticals.

For Media Inquiries, Please Contact:

Call: +1 628 895 8081 | +91 120 4278433

Email: sales@marknteladvisors.com

Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511

Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India